StockData

SS Innovations International vs Utah Medical Products

SSII and UTMD side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How SSII and UTMD compare

SS Innovations International is the larger company, worth 1.2 times as much as Utah Medical Products ($267M against $229M).

Utah Medical Products pays a dividend yielding 1.7%; SS Innovations International does not pay one.

Utah Medical Products scores higher on the StockData Score (10 against 8 for SS Innovations International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricSSIIUTMD
Size and price
Market cap$267M$229M
Share price$1.33$72.02
Change, 1 year−78.6%30.0%
Change, 5 years–−40.1%
Beta (5Y)0.900.25
Employees81140
StockData Score
Total score810 (better)
Valuation score23 (better)
Growth score2 (better)0
Performance score2 (better)1
Health score24 (better)
Dividend score02 (better)
Valuation
P/E–22.0×
P/S5.1× (better)6.4×
P/B5.0×1.9× (better)
EV/EBITDA–13.8×
P/FCF–20.0×
FCF yield–5.0%
Fair value$3.56$75.66
Margin of safety62.6% (better)4.8%
Growth
Revenue growth (TTM)89.7%–
Revenue growth, 5Y average–−1.8%
EPS growth, 5Y average–3.4%
Profitability
Gross margin47.6%57.9% (better)
Operating margin−16.2%28.4% (better)
Net margin−23.7%–
FCF margin–31.7%
Return on equity−26.1%–
Return on invested capital−20.9%23.9% (better)
Financial health
Debt / equity–0.00
Net debt / EBITDA–−8.51
Interest coverage−7.4×–
Current ratio2.2448.62 (better)
Altman Z-score3.5257.18 (better)
Piotroski F-score5–
Dividends and buybacks
Dividend yield–1.7%
Buyback yield–0.81%
Shareholder yield0.00%2.5% (better)
Ownership
Held by institutions0.82%72.8%
Held by insiders76.7%7.3%
Insider net buying, 12 months$5.1M (better)$66.8K
Short interest, % of float0.14%5.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.